Pitfalls in the diagnosis of glycine encephalopathy (non‐ketotic hyperglycinemia)
2002; Wiley; Volume: 44; Issue: 10 Linguagem: Inglês
10.1111/j.1469-8749.2002.tb00275.x
ISSN1469-8749
AutoresStanley H. Korman, Alisa Gutman,
Tópico(s)Mitochondrial Function and Pathology
ResumoDevelopmental Medicine & Child NeurologyVolume 44, Issue 10 p. 712-720 Free Access Pitfalls in the diagnosis of glycine encephalopathy (non-ketotic hyperglycinemia) Stanley H Korman MBBS FRACP, Corresponding Author Stanley H Korman MBBS FRACP Department of Clinical Biochemistry, Hadassah University Hospital, Jerusalem, Israel. *Correspondence to first author at Clinical Biochemistry, Hadassah University Hospital, PO Box 12000, Jerusalem 91120, Israel. E-mail: [email protected] aMendelian Inheritance in Man; for more information see: www.ncbi.nim.nih.gov/OmimSearch for more papers by this authorAlisa Gutman MD, Alisa Gutman MD Department of Clinical Biochemistry, Hadassah University Hospital, Jerusalem, Israel.Search for more papers by this author Stanley H Korman MBBS FRACP, Corresponding Author Stanley H Korman MBBS FRACP Department of Clinical Biochemistry, Hadassah University Hospital, Jerusalem, Israel. *Correspondence to first author at Clinical Biochemistry, Hadassah University Hospital, PO Box 12000, Jerusalem 91120, Israel. E-mail: [email protected] aMendelian Inheritance in Man; for more information see: www.ncbi.nim.nih.gov/OmimSearch for more papers by this authorAlisa Gutman MD, Alisa Gutman MD Department of Clinical Biochemistry, Hadassah University Hospital, Jerusalem, Israel.Search for more papers by this author First published: 13 February 2007 https://doi.org/10.1111/j.1469-8749.2002.tb00275.xCitations: 50AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Hamosh A, Johnston MV. (2001) Non-ketotic hyperglycinemia. In: CR Scriver, AL Beaudet, WS Sly, D Valle, editors. The Metabolic & Molecular Bases of Inherited Disease. 8th edn. New York : McGrawHill, p 2065–78. Google Scholar 2 Tada K, Kure S. (1993) Non-ketotic hyperglycinaemia: molecular lesion, diagnosis, and pathophysiology. Journal of Inherited Metabolic Disease 16: 691–703. 10.1007/BF00711901 CASPubMedWeb of Science®Google Scholar 3 Sakata Y, Owada Y, Sata K, Kojima K, Hisanaga K, Shinka T, Suzuki Y, Aoki Y, Satoh J, Kondo H, Matsubara Y, Kure S. (2001) Structure and expression of the glycine cleavage system in rat central nervous system. Brain Research. Molecular Brain Research 94: 119–30. 10.1016/S0169-328X(01)00225-X CASPubMedWeb of Science®Google Scholar 4 Holmgren G, Blomquist HK. (1977) Non-ketotic hyperglycinemia in two sibs with mild psychoneurological symptoms. Neuropediatrics 8: 67–72. 10.1055/s-0028-1091506 CASPubMedWeb of Science®Google Scholar 5 Ando T, Nyhan WL, Bicknell J, Harris R, Stern J. (1978) Non-ketotic hyperglycinaemia in a family with an unusual phenotype. Journal of Inherited Metabolic Disease 1: 79–83. 10.1007/BF01805677 CASPubMedGoogle Scholar 6 Frazier DM, Summer GK, Chamberlin HR. (1978) Hyperglycinuria and hyperglycinemia in two siblings with mild developmental delays. American Journal of Diseases of Children 132: 777–81. CASPubMedWeb of Science®Google Scholar 7 Steiman GS, Yudkoff M, Berman PH, Blazer-Yost B, Segal S. (1979) Late-onset non-ketotic hyperglycinemia and spinocerebellar degeneration. Journal of Pediatrics 94: 907–11. 10.1016/S0022-3476(79)80211-5 CASPubMedWeb of Science®Google Scholar 8 Trauner DA, Page T, Greco C, Sweetman L, Kulovich S, Nyhan WL. (1981) Progressive neurodegenerative disorder in a patient with non-ketotic hyperglycinemia. Journal of Pediatrics 98: 272–5. 10.1016/S0022-3476(81)80659-2 CASPubMedWeb of Science®Google Scholar 9 Flannery DB, Pellock J, Bousounis D, Hunt P, Nance C, Wolf B. (1983) Non-ketotic hyperglycinemia in two retarded adults: a mild form of infantile non-ketotic hyperglycinemia. Neurology 33: 1064–6. 10.1212/WNL.33.8.1064 CASPubMedWeb of Science®Google Scholar 10 Borrone C, Bachmann C, Di Rocco M, Tada K, Hayasaka K, Gatti R. (1986) Atypical non-ketotic hyperglycinaemia. Journal of Inherited Metabolic Disease 9: 402–3. 10.1007/BF01800496 CASPubMedWeb of Science®Google Scholar 11 Haan EA, Kirby DM, Tada K, Hayasaka K, Danks DM. (1986) Difficulties in assessing the effect of strychnine on the outcome of non-ketotic hyperglycinaemia. Observations on sisters with a mild T-protein defect. European Journal of Pediatrics 145: 267–70. 10.1007/BF00439398 CASPubMedWeb of Science®Google Scholar 12 Singer HS, Valle D, Hayasaka K, Tada K. (1989) Non-ketotic hyperglycinemia: studies in an atypical variant. Neurology 39: 286–8. 10.1212/WNL.39.2.286 CASPubMedWeb of Science®Google Scholar 13 Christodoulou J, Kure S, Hayasaka K, Clarke JT. (1993) Atypical non-ketotic hyperglycinemia confirmed by assay of the glycine cleavage system in lymphoblasts. Journal of Pediatrics 123: 100–2. 10.1016/S0022-3476(05)81550-1 CASPubMedWeb of Science®Google Scholar 14 Tanaka Y, Miyazaki M, Tsuda M, Murai K, Kuzuhara S. (1993) Blindness due to non-ketotic hyperglycinemia: report of a 38-year-old - the oldest case to date. Internal Medicine 32: 641–2. 10.2169/internalmedicine.32.641 CASPubMedWeb of Science®Google Scholar 15 Steiner RD, Sweetser DA, Rohrbaugh JR, Dowton SB, Toone JR, Applegarth DA. (1996) Non-ketotic hyperglycinemia: atypical clinical and biochemical manifestations. Journal of Pediatrics 128: 243–6. 10.1016/S0022-3476(96)70399-2 CASPubMedWeb of Science®Google Scholar 16 Wraith JE. (1996) Non-kinetic hyperglycinaemia: prolonged survival in a patient with a mild variant. Journal of Inherited Metabolic Disease 19: 695–6. 10.1007/BF01799847 CASPubMedWeb of Science®Google Scholar 17 Jackson AH, Applegarth DA, Toone JR, Kure S, Levy HL. (1999) Atypical non-ketotic hyperglycinemia with normal cerebrospinal fluid to plasma glycine ratio. Journal of Child Neurology 14: 464–7. 10.1177/088307389901400710 CASPubMedWeb of Science®Google Scholar 18 Wiltshire EJ, Poplawski NK, Harrison JR, Fletcher JM. (2000) Treatment of late-onset non-ketotic hyperglycinaemia: effectiveness of imipramine and benzoate. Journal of Inherited Metabolic Disease 23: 15–21. 10.1023/A:1005690611675 CASPubMedWeb of Science®Google Scholar 19 Neuberger JM, Schweitzer S, Rolland MO, Burghard R. (2000) Effect of sodium benzoate in the treatment of atypical non-ketotic hyperglycinaemia. Journal of Inherited Metabolic Disease 23: 22–6. 10.1023/A:1005642728513 CASPubMedWeb of Science®Google Scholar 20 Cataltepe S, van Marter LJ, Kozakewich H, Wessel DL, Lee PJ, Levy HL. (2000) Pulmonary hypertension associated with non-ketotic hyperglycinaemia. Journal of Inherited Metabolic Disease 23: 137–44. 10.1023/A:1005613715351 CASPubMedWeb of Science®Google Scholar 21 Schiffmann R, Kaye EM, Willis JK, Africk D, Ampola M. (1989) Transient neonatal hyperglycinemia. Annals of Neurology 25: 201–3. 10.1002/ana.410250218 CASPubMedWeb of Science®Google Scholar 22 Luder AS, Davidson A, Goodman SI, Greene CL. (1989) Transient non-ketotic hyperglycinemia in neonates. Journal of Pediatrics 114: 1013–5. 10.1016/S0022-3476(89)80453-6 CASPubMedWeb of Science®Google Scholar 23 Eyskens FJ, van Doorn JW, Marien E. (1992) Neurologic sequelae in transient non-ketotic hyperglycinemia of the neonate. Journal of Pediatrics 121: 620–1. 10.1016/S0022-3476(05)81158-8 CASPubMedWeb of Science®Google Scholar 24 Zammarchi E, Donati MA, Ciani F. (1995) Transient neonatal non-ketotic hyperglycinemia: a 13-yearfollow-up. Neuropediatrics 26: 328–30. 10.1055/s-2007-979785 CASPubMedWeb of Science®Google Scholar 25 Alejo J, Rincon P, Vaquerizo J, Gil C, Plasencia A, Gallardo R. (1997) Case report. Transient non-ketotic hyperglycinaemia: ultrasound, CT, and MRI. Neuroradiology 39: 658–60. 10.1007/s002340050486 CASPubMedWeb of Science®Google Scholar 26 Maeda T, Inutsuka M, Goto K, Izumi T. (2000) Transient non-ketotic hyperglycinemia in an asphyxiated patient with pyridoxine-dependent seizures. Pediatric Neurology 22: 225–7. 10.1016/S0887-8994(99)00138-1 CASPubMedWeb of Science®Google Scholar 27 Von Wendt L, Hirvasniemi A, Simila S. (1979) Non-ketotic hyperglycinemia. A genetic study of 13 Finnish families. Clinical Genetics 15: 411–7. 10.1111/j.1399-0004.1979.tb01773.x CASPubMedWeb of Science®Google Scholar 28 Toone JR, Applegarth DA. (1989) Use of placental enzyme analysis in assessment of the newborn at riskfor non-ketotic hyperglycinaemia (NKH). Journal of Inherited Metabolic Disease 12: 281–5. 10.1007/BF01799218 CASPubMedWeb of Science®Google Scholar 29 Applegarth DA, Toone JR, Lowry RB. (2000) Incidence of inborn errors of metabolism in British Columbia, 1969–1996. Pediatrics www.pediatrics.org/cgi/content/full/105/1/e10. Google Scholar 30 Boneh A, Degani Y, Harari M. (1996) Prognostic clues and outcome of early treatment of non-ketotic hyperglycinemia. Pediatric Neurology 15: 137–41. 10.1016/0887-8994(96)00158-0 PubMedWeb of Science®Google Scholar 31 Kure S, Mandel H, Rolland MO, Sakata Y, Shinka T, Drugan A, Boneh A, Tada K, Matsubara Y, Narisawa K. (1998) A missense mutation (His42Arg) in the T-protein gene from a large Israeli-Arab kindred with non-ketotic hyperglycinemia. Human Genetics 102: 430–4. 10.1007/s004390050716 CASPubMedWeb of Science®Google Scholar 32 Kure S, Rolland MO, Leisti J, Mandel H, Sakata Y, Tada K, Matsubara Y, Narisawa K. (1999) Prenatal diagnosis of non-ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutations. Prenatal Diagnosis 19: 717–20. 10.1002/(SICI)1097-0223(199908)19:8 3.0.CO;2-L CASPubMedWeb of Science®Google Scholar 33 Hayasaka K, Tada K, Kikuchi G, Winter S, Nyhan WL. (1983) Non-ketotic hyperglycinemia: two patients with primary defects of P-protein and T-protein respectively, in the glycine cleavage system. Pediatric Research 17: 967–70. 10.1203/00006450-198312000-00008 CASPubMedWeb of Science®Google Scholar 34 Kure S, Narisawa K, Tada K. (1992) Enzymatic diagnosis of non-ketotic hyperglycinemia with lymphoblasts. Journal of Pediatrics 120: 95–8. 10.1016/S0022-3476(05)80610-9 CASPubMedWeb of Science®Google Scholar 35 Applegarth DA, Toone JR. (2001) Non-ketotic hyperglycinemia (glycine encephalopathy): laboratory diagnosis. Molecular Genetics and Metabolism 74: 139–46. 10.1006/mgme.2001.3224 CASPubMedWeb of Science®Google Scholar 36 Kure S, Takayanagi M, Narisawa K, Tada K, Leisti J. (1992) Identification of a common mutation in Finnish patients with non-ketotic hyperglycinemia. Journal of Clinical Investigation 90: 160–4. 10.1172/JCI115831 CASPubMedWeb of Science®Google Scholar 37 Toone JR, Applegarth DA, Coulter-Mackie MB, James ER. (2000) Biochemical and molecular investigations of patients with non-ketotic hyperglycinemia. Molecular Genetics and Metabolism 70: 116–21. 10.1006/mgme.2000.3000 CASPubMedWeb of Science®Google Scholar 38 Toone JR, Applegarth DA, Coulter-Mackie MB, James ER. (2001) Identification of the first reported splice site mutation (IVS7–1G-A) in the aminomethyltransferase (T-protein) gene (AMT) of the glycine cleavage complex in 3 unrelated families with non-ketotic hyperglycinemia. Human Mutatation 17: 76. 10.1002/1098-1004(2001)17:1 3.0.CO;2-0 CASPubMedWeb of Science®Google Scholar 39 Toone JR, Applegarth DA, Coulter-Mackie MB, James ER. (2001) Recurrent mutations in P- and T-proteins of the glycine cleavage complex and a novel T-protein mutation N1 45I): a strategy for the molecular investigation of patients with non-ketotic hyperglycinemia (NKH). Molecular Genetics and Metabolism 72: 322–5. 10.1006/mgme.2001.3158 CASPubMedWeb of Science®Google Scholar 40 Kure S, Kojima K, Kudo T, Kanno K, Aoki Y, Suzuki Y, Shinka T, Sakata Y, Narisawa K, Matsubara Y. (2001) Chromosomal localization, structure, single-nucleotide polymorphisms, and expression of the human H-protein gene of the glycine cleavage system (GCSH), a candidate gene for non-ketotic hyperglycinemia. Journal of Human Genetics 46: 378–84. 10.1007/s100380170057 CASPubMedWeb of Science®Google Scholar 41 Isobe M, Koyata H, Sakakibara T, Momoi-Isobe K, Hiraga K. (1994) Assignment of the true and processed genes for human glycine decarboxylase to 9p23–24 and 4q12. Biochemical and Biophysical Research Communications 30: 1483–7. 10.1006/bbrc.1994.2352 CASWeb of Science®Google Scholar 42 Takayanagi M, Kure S, Sakata Y, Kurihara Y, Ohya Y, Kajita M, Tada K, Matsubara Y, Narisawa K. (2000) Human glycine decarboxylase gene (GLDC) and its highly conserved processed pseudogene (psiGLDC): their structure and expression, and the identification of a large deletion in a family with non-ketotic hyperglycinemia. Human Genetics 106: 298–305. 10.1007/s004390051041 CASPubMedWeb of Science®Google Scholar 43 Randak C, Rosschinger W, Rolinski B, Hadorn HB, Applegarth DA, Roscher AA. (2000) Three siblings with non-ketotic hyperglycinaemia, mildly elevated plasma homocysteine concentrations, and moderate methylmalonic aciduria. Journal of Inherited Metabolic Disease 23: 520–2. 10.1023/A:1005667707355 CASPubMedWeb of Science®Google Scholar 44 Kolvraa S. (1979) Inhibition of the glycine cleavage system by branched-chain amino acid metabolites. Pediatric Research 13: 889–93. 10.1203/00006450-197908000-00004 PubMedWeb of Science®Google Scholar 45 Hayasaka K, Narisawa K, Satoh T, Tateda H, Metoki K, Tada K, Hiraga K, Aoki T, Kawakami T, Akamatsu H, Matsuo N. (1982) Glycine cleavage system in ketotic hyperglycinemia: a reduction of H-protein activity. Pediatric Research 16: 5–7. 10.1203/00006450-198201001-00002 CASPubMedWeb of Science®Google Scholar 46 Hayasaka K, Tada K. (1983) Effects of the metabolites of the branched-chain amino acids and cysteamine on the glycine cleavage system. Biochemistry International 6: 225–30. CASPubMedWeb of Science®Google Scholar 47 Brandt NJ, Brandt S, Rasmussen K, Schonheyder F. (1974) Hyperglyceric-acidaemia with hyperglycinaemia: a new inborn error of metabolism. British Medical Journal 4: 344.(Letter). 10.1136/bmj.4.5940.344-a CASPubMedWeb of Science®Google Scholar 48 Wadman SK, Duran M, Ketting D, Bruinvis L, de Bree PK, Kamerling JP, Gerwig GJ, Vliegenthart JF, Przyrembel H, Becker K, Bremer HJ. (1976) D-glyceric acidemia in a patient with chronic metabolic acidosis. Clinica Chimica Acta 71: 477–84. 10.1016/0009-8981(76)90099-1 CASPubMedWeb of Science®Google Scholar 49 Grandgeorge D, Favier A, Bost M, Frappat P, Boujet C, Garrel S, Stoebner P. (1980) L'acidémie D-glycérique. Apropos d'une nouvelle observation anatomo-clinique. Archives Francaises dePediatrie 37: 577–84. (In French). Web of Science®Google Scholar 50 Duran M, Beemer FA, Bruinvis L, Ketting D, Wadman SK. (1987) D-glyceric acidemia: an inborn error associated with fructose metabolism. Pediatric Research 21: 502–6. 10.1203/00006450-198705000-00016 CASPubMedWeb of Science®Google Scholar 51 Fontaine M, Porchet N, Largillière C, Marrakchi S, Lhermitte M, Aubert JP, Degand P. (1989) Biochemical contribution to diagnosis and study of a new case of D-glyceric acidemia/aciduria. Clinical Chemistry 35: 2148–51. CASPubMedWeb of Science®Google Scholar 52 Bonham JR, Stephenson TJ, Carpenter KH, Rattenbury JM, Cromby CH, Pollitt RJ, Hull D. (1990) D(+)-glyceric aciduria: etiology and clinical consequences. Pediatric Research 28: 38–41. 10.1203/00006450-199007000-00009 CASPubMedWeb of Science®Google Scholar 53 Sewell AC, Moritz A, Duran M. (1997) D-(+)-Glyceric aciduria in an Afghan hound. Journal of Inherited Metabolic Disease 20: 395–6. 10.1023/A:1005346532138 CASPubMedWeb of Science®Google Scholar 54 Kolvraa S, Rasmussen K, Brandt NJ. (1976) D-glyceric acidemia: biohcemical studies of a new syndrome. Pediatric Research 10: 825–30. 10.1203/00006450-197610000-00003 CASPubMedWeb of Science®Google Scholar 55 van Schaftingen E. (1989) D-glycerate kinase deficiency as a cause of D-glyceric aciduria. FEBS Letters 243: 127–31. 10.1016/0014-5793(89)80113-9 CASPubMedWeb of Science®Google Scholar 56 Largillière C, Fontaine M, Jakobs C, Lemaitre JF. (1992) D-glyceric aciduria: new development. Journal of Inherited Metabolic Disease 15: 942. 10.1007/BF01800242 PubMedWeb of Science®Google Scholar 57 Brandt NJ, Rasmussen K, Brandt S, Kolvraa S, Schonheyder F. (1976) D-glyceric-acidaemia and non-ketotic hyperglycinaemia. Clinical and laboratory findings in anew syndrome. Acta Paediatrica Scandinavica 65: 17–22. 10.1111/j.1651-2227.1976.tb04401.x CASPubMedWeb of Science®Google Scholar 58 Kolvraa S, Christensen E, Brandt NJ. (1980) Studies of the glycine metabolism in a patient with D-glyceric acidemia and hyperglycinemia. Pediatric Research 14: 1029–34. 10.1203/00006450-198009000-00003 CASPubMedWeb of Science®Google Scholar 59 Brandt NJ, Christensen E, Kolvraa S, Rasmussen K. (1977) D-glyceric-acidaemia in non-ketotic hyperglycinaemia: a new inborn error of metabolism. Annals of Clinical Biochemistry 14: 142–3. 10.1177/000456327701400131 CASPubMedWeb of Science®Google Scholar 60 Kolvraa S, Gregersen N, Brandt NJ. (1980) Excretion of short-chain N-acylglycines in the urine of a patient with D-glyceric acidemia. Clinica Chimica Acta 106: 215–21. 10.1016/0009-8981(80)90174-6 CASPubMedWeb of Science®Google Scholar 61 Kolvraa S, Rosleff F, Brandt NJ. (1983) Normal glycine transport in cultured diploid fibroblasts from hyperglycinaemic subjects. Journal of Inherited Metabolic Disease 6: 82–4. 10.1007/BF02338974 CASPubMedWeb of Science®Google Scholar 62 Kolvraa S, Gregersen N, Christensen E. (1984) In vivo studies on the metabolic derangement in a patient with D-glyceric acidaemia and hyperglycinaemia. Journal of Inherited Metabolic Disease 7: 49–52. 10.1007/BF01805799 CASPubMedWeb of Science®Google Scholar 63 Subhedar NV, Isherwood DM, Davidson DC. (1996) Hyperglycinaemia in a child with carbohydrate-deficient glycoprotein syndrome type I. Journal of Inherited Metabolic Disease 19: 796–7. 10.1007/BF01799178 CASPubMedWeb of Science®Google Scholar 64 Jaeken J, Stibler H. (1989) A newly recognized inherited neurological disease with carbohydrate-deficient secretory glycoproteins. In: L Wetterberg, editor. Genetics of Neuropsychiatric Diseases. Wenner-Gren Center International Symposium Series. Vol. 51. New York : Macmillan. p 69–80. 10.1007/978-1-349-10729-2_7 Google Scholar 65 Pavone L, Mollica F, Levy HL. (1975) Asymptomatic type II hyperprolinaemia associated with hyperglycinaemia in three sibs. Archives of Disease in Childhood 50: 637–41. 10.1136/adc.50.8.637 CASPubMedWeb of Science®Google Scholar 66 Holt LE Jr, Snyderman SE, Norton PM, Roitman E, Finch J. (1963) The plasma aminogram in kwashiorkor. Lancet 2: 1343–8. 10.1016/S0140-6736(63)90734-7 Web of Science®Google Scholar 67 Felig P, Owen OE, Wahren J, Cahill GF Jr. (1969) Amino acid metabolism during prolonged starvation. Journal of Clinical Investigation 48: 584–94. 10.1172/JCI106017 CASPubMedWeb of Science®Google Scholar 68 Applegarth DA, Poon S. (1975) Interpretation of elevated blood glycine levels in children. Clinica Chimica Acta 63: 49–54. 10.1016/0009-8981(75)90377-0 CASPubMedWeb of Science®Google Scholar 69 Jaeken J, Corbeel L, Casaer P, Carchon H, Eggermont E, Eeckels R. (1977) Dipropylacetate (valproate) and glycine metabolism. Lancet 2: 617.(Letter). 10.1016/S0140-6736(77)91475-1 PubMedWeb of Science®Google Scholar 70 Simila S, Von Wendt L, Linna SL, Saukkonen AL, Huhtaniemi I. (1979) Dipropylacetate and hyperglycinemia. Neuropadiatrie 10: 158–60. 10.1055/s-0028-1085322 CASPubMedWeb of Science®Google Scholar 71 Mortensen PB, Kolvraa S, Christensen E. (1980) Inhibition of the glycine cleavage system: hyperglycinemia and hyperglycinuria caused by valproic acid. Epilepsia 21: 563–9. 10.1111/j.1528-1157.1980.tb04310.x PubMedWeb of Science®Google Scholar 72 Ciani F, Pasquini E, Ciardetti A, Donati MA, Zammarchi E. (1997) Hyperglycinemia in clinical-laboratory practice. LaPediatria Medica e Chirurgica 19: 109–12. CASGoogle Scholar 73 Iinuma K, Hayasaka K, Narisawa K, Tada K, Hori K. (1988) Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid. European Journal of Pediatrics 148: 267–9. 10.1007/BF00441418 CASPubMedWeb of Science®Google Scholar 74 Kochi H, Hayasaka K, Hiraga K, Kikuchi G. (1979) Reduction of the level of the glycine cleavage system in the rat liver resulting from administration of dipropylacetic acid: an experimental approach to hyperglycinemia. Archives of Biochemistry & Biophysics 198: 589–97. 10.1016/0003-9861(79)90535-6 CASPubMedWeb of Science®Google Scholar 75 Martin-Gallardo A, Rodriguez P, Lopez M, Benavides J, Ugarte M. (1985) Effects of dipropylacetate on the glycine cleavage enzyme system and glycine levels. A possible experimental approach to non-ketotic hyperglycinemia. Biochemical Pharmacology 34: 2877–82. 10.1016/0006-2952(85)90010-3 CASPubMedWeb of Science®Google Scholar 76 Cherruau B, Mangeot M, Demelier JF, Charpentier C, Pelletier C, Lemonnier A. (1981) Metabolic abnormalities observed in the rat after administration of sodium dipropylacetate. Toxicology Letters 8: 39–42. 10.1016/0378-4274(81)90135-1 CASPubMedWeb of Science®Google Scholar 77 Hahn RG. (1997) Irrigating fluids in endoscopic surgery. British Journal Urology 79: 669–80. 10.1046/j.1464-410X.1997.00150.x CASPubMedWeb of Science®Google Scholar 78 Parvy P, Bardet J, Rabier D, Nedellec J, Kamoun R. (1991) A false hyperglycinaemia. Journal of Inherited Metabolic Disease 14: 112. 10.1007/BF01804401 CASPubMedWeb of Science®Google Scholar 79 Perry TL, Urquhart N, MacLean J, Evans ME, Hansen S, Davidson GF, Applegarth DA, MacLeod PJ, Lock JE. (1975) Non-ketotic hyperglycinemia. Glycine accumulation due to absence of glycine cleavage in brain. New England Journal of Medicine 292: 1269–73. 10.1056/NEJM197506122922404 PubMedGoogle Scholar 80 Ruppel RA, Kochanek PM, Adelson PD, Rose ME, Wisniewski SR, Bell MJ, Clark RS, Marion DW, Graham SH. (2001) Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse. Journal of Pediatrics 138: 18–25. 10.1067/mpd.2001.110979 CASPubMedWeb of Science®Google Scholar 81 Roldan A, Figueras-Aloy J, Deulofeu R, Jimenez R. (1999) Glycine and other neurotransmitter amino acids in cerebrospinal fluid in perinatal asphyxia and neonatal hypoxic-ischaemic encephalopathy. Acta Paediatrica 88: 1137–41. 10.1080/08035259950168225 CASPubMedWeb of Science®Google Scholar 82 Biasioli S, D'Andrea G, Feriani M, Chiaramonte S, Fabris A, Ronco C, La Greca G. (1986) Uremic encephalopathy: an updating. Clinical Nephrology 25: 57–6. PubMedWeb of Science®Google Scholar 83 van der Knaap MS, Wevers RA, Kure S, Gabreels FJ, Verhoeven NM, van Raaij-Selten B, Jaeken J. (1999) Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. Journal of Child Neurology 14: 728–31. 10.1177/088307389901401108 CASPubMedWeb of Science®Google Scholar 84 Leegwater PAJ, Vermeulen G, Könst AAM, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CGM, Lemmers RJLF, Frants RR, Oudejans CBM, Schutgens RBH, Pronk JC, van der Knapp MS. (2001) Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nature Genetics 29: 383–8. 10.1038/ng764 CASPubMedWeb of Science®Google Scholar 85 Kalviainen R, Halonen T, Pitkanen A, Riekkinen PJ. (1993) Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies. Journal of Neurochemistry 60: 1244–50. 10.1111/j.1471-4159.1993.tb03283.x CASPubMedWeb of Science®Google Scholar 86 Halonen T, Lehtinen M, Pitkanen A, Ylinen A, Riekkinen PJ. (1988) Inhibitory and excitatory amino acids in CSF of patients suffering from complex partial seizures during chronic treatment with gamma-vinyl GABA (vigabatrin). Epilepsy Research 2: 246–52. 10.1016/0920-1211(88)90015-0 CASPubMedWeb of Science®Google Scholar 87 Pitkanen A, Matilainen R, Ruutiainen T, Lehtinen M, Riekkinen P. (1988) Effect of vigabatrin (gamma-vinyl GABA) on amino acid levels in CSF of epileptic patients. Journal of Neurology, Neurosurgery & Psychiatry 51: 1395–400. 10.1136/jnnp.51.11.1395 CASPubMedWeb of Science®Google Scholar 88 Perry TL, Hansen S, Kennedy J. (1975) CSF amino acids and plasma-CSF amino acid ratios in adults. Journal of Neurochemistry 24: 587–58. 10.1111/j.1471-4159.1975.tb07680.x CASPubMedWeb of Science®Google Scholar 89 Patten BM. (1968) How much blood makes CSF fluid bloody Journal of the American Medical Association 206: 378. (Letter). 10.1001/jama.206.2.378c CASPubMedWeb of Science®Google Scholar 90 Kornhuber ME, Kornhuber J, Kornhuber AW, Hartmann GM. (1986) Positive correlation between contamination by blood and amino acid levels in cerebrospinal fluid of the rat. Neuroscience Letters 69: 212–5. 10.1016/0304-3940(86)90606-3 CASPubMedWeb of Science®Google Scholar 91 Phang JM, Hu CA, Valle D. (2001) Disorders of proline and hydroxyproline metabolism. In: CR Scriver, AL Beaudet, WS Sly, D Valle, editors. The Metabolic & Molecular Bases of Inherited Disease. 8th edn. New York : McGraw-Hill. p 1821–38. Google Scholar 92 Chesney RW. (2001) Iminoglycinuria. In: CR Scriver, AL Beaudet, WS Sly, D Valle, editors. The Metabolic & Molecular Bases of Inherited Disease. 8th edn. New York : McGraw-Hill. p 4971–81. Google Scholar 93 Greene ML, Lietman PS, Rosenberg LE, Seegmiller JE. (1973) Familial hyperglycinuria. New defect in renal tubular transport of glycine and imino acids. American Journal of Medicine 54: 265–71. 10.1016/0002-9343(73)90232-5 CASPubMedWeb of Science®Google Scholar 94 Oberiter V, Puretic Z, Fabecic-Sabadi V. (1978) Hyperglycinuria with nephrolithiasis. European Journal of Pediatrics 127: 279–85. 10.1007/BF00493544 CASPubMedWeb of Science®Google Scholar 95 Käser H, Cottier P, Antener I. (1962) Glucoglycinuria, a new familial syndrome. Journal of Pediatrics 61: 386–394. 10.1016/S0022-3476(62)80369-2 CASPubMedWeb of Science®Google Scholar 96 Garcia-Castro JM, Isales-Forsythe CM, Levy HL, Shih VE, LaoVelez CR, Gonzalez-Rios MD, Reyes de Torres LC. (1982) Prenatal diagnosis of non-ketotic hyperglycinemia. New England Journal of Medicine 306: 79–81. 10.1056/NEJM198201143060205 CASPubMedWeb of Science®Google Scholar 97 Mesavage C, Nance CS, Flannery DB, Weiner DL, Suchy SF, Wolf B. (1983) Glycine/serine ratios in amniotic fluid: an unreliable indicator for the prenatal diagnosis of non-ketotic hyperglycinemia. Clinical Genetics 23: 354–8. 10.1111/j.1399-0004.1983.tb00445.x CASPubMedWeb of Science®Google Scholar 98 Toone JR, Applegarth DA, Levy HL. (1994) Prenatal diagnosis of non-ketotic hyperglycinaemia: experience in 50 at-risk pregnancies. Journal of Inherited Metabolic Disease 17: 342–4. 10.1007/BF00711825 CASPubMedWeb of Science®Google Scholar 99 Hayasaka K, Tada K, Fueki N, Aikawa J. (1990) Prenatal diagnosis of non-ketotic hyperglycinemia: enzymatic analysis of the glycine cleavage system in chorionic villi. Journal of Pediatrics 116: 444–5. 10.1016/S0022-3476(05)82841-0 CASPubMedWeb of Science®Google Scholar 100 Applegarth DA, Toone JR, Rolland MO, Black SH, Yim DK, Bemis G. (2000) Non-concordance of CVS and liver glycine cleavage enzyme in three families with non-ketotic hyperglycinaemia (NKH) leading to false negative prenatal diagnoses. Prenatal Diagnosis 20: 367–70. 10.1002/(SICI)1097-0223(200005)20:5 3.0.CO;2-E CASPubMedWeb of Science®Google Scholar 101 Hayasaka K, Tada K, Fueki N, Nakamura Y, Nyhan WL, Schmidt K, Packman S, Seashore MR, Haan E, Danks DM, Schutgens RBH. (1987) Non-ketotic hyperglycinemia: analyses of glycine cleavage system in typical and atypical cases. Journal of Pediatrics 110: 873–7. 10.1016/S0022-3476(87)80399-2 PubMedWeb of Science®Google Scholar 102 Nanao K, Okamura-Ikeda K, Motokawa Y, Danks DM, Baumgartner ER, Takada G, Hayasaka K. (1994) Identification of the mutations in the T-protein gene causing typical and atypical non-ketotic hyperglycinemia. Human Genetics 93: 655–8. 10.1007/BF00201565 CASPubMedWeb of Science®Google Scholar 103 Brandt NJ, Christensen E. (1984) Omega-aminoaciduria induced by gamma-vinyl GABA. Lancet 1: 450–1. 10.1016/S0140-6736(84)91777-X CASPubMedWeb of Science®Google Scholar 104 Vallat C, Rivier F, Bellet H, Magnan de Bornier B, Mion H, Echenne B. (1996) Treatment with vigabatrin may mimic alpha-aminoadipic aciduria. Epilepsia 37: 803–5. 10.1111/j.1528-1157.1996.tb00655.x CASPubMedWeb of Science®Google Scholar Citing Literature Volume44, Issue10October 2002Pages 712-720 ReferencesRelatedInformation
Referência(s)